DIRECTVLP
Live / Allowed — Publication / registration review complete (as of 25 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99466065
- Mark type
- Stylized text
- Filed
- 28 Oct 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- J. Matthew Buchanan
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Oral vaccines; Modified cells for medical or clinical use; Yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
Owner
- Esperovax, Inc., Plymouth, MI, US
Prosecution history
- 19 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — ASSIGNED TO EXAMINER
- 28 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2025 — NEW APPLICATION ENTERED